Detalles de la búsqueda
1.
Differential immunomodulatory activity of tumor cell death induced by cancer therapeutic toll-like receptor ligands.
Cancer Immunol Immunother
; 65(6): 689-700, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27034235
2.
Results from a safety cohort of patients with renal anemia receiving the biosimilar epoetinzeta: The PASCO I study.
Clin Nephrol
; 84(5): 280-8, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26396097
3.
Human tumor-induced and naturally occurring Treg cells differentially affect NK cells activated by either IL-2 or target cells.
Eur J Immunol
; 41(12): 3564-73, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21905023
4.
Toll-like receptor 4 single-nucleotide polymorphisms Asp299Gly and Thr399Ile in head and neck squamous cell carcinomas.
J Transl Med
; 9: 139, 2011 Aug 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-21854645
5.
HMGB1 is overexpressed in tumor cells and promotes activity of regulatory T cells in patients with head and neck cancer.
Oral Oncol
; 48(5): 409-16, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22265157
Resultados
1 -
5
de 5
1
Próxima >
>>